1253 Results

People

  1. Motzer
    Motzer
  2. Kingham
    Kingham
  3. Hudis
    Hudis
  4. Abou-Alfa
    Abou-Alfa
  5. Horwitz
    Horwitz
  6. Zelenetz
    Zelenetz
  7. Kris
    Kris
  8. Perales
    Perales
  9. Aghajanian
    Aghajanian
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)
  7. Population Sciences Research Program (170)
  8. Epidemiology and Biostatistics (122)
  9. Center for Pancreatic Cancer Research (110)
  10. Genitourinary Oncology Service (109)
  1. "multicenter study"
Formats
  1. Journal Article (1219)
  2. Research Letter (12)
  3. Conference Paper (7)
  4. Correspondence (6)
  5. Review (5)
  6. Guidelines (2)
  7. Editorial (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (680)
  2. Solid Tumor Oncology Division (431)
  3. Hematologic Malignancies, Division of (230)
  4. Surgery (201)
  5. Center for Hematologic Malignancies (186)
  6. Survivorship Research (182)

More Groups

People
  1. Robert Motzer (47)
  2. T Peter Kingham (31)
  3. Clifford Hudis (19)
  4. Andrew Zelenetz (18)
  5. Ghassan Abou-Alfa (18)
  6. Steven Horwitz (18)

More People

Years
  1. 2025 (86)
  2. 2024 (191)
  3. 2023 (130)
  4. 2022 (83)
  5. 2021 (50)
  6. 2020 (63)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. Lancet Oncology (57)
  3. New England Journal of Medicine (56)
  4. Clinical Cancer Research (46)
  5. Blood (44)
  6. Cancer (36)

More Publications

Publishers
  1. Elsevier Inc. (152)
  2. Elsevier Science, Inc. (137)
  3. American Society of Clinical Oncology (124)
  4. Springer (84)
  5. Oxford University Press (79)
  6. Wiley Blackwell (71)

More Publishers

Results (1253)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of weekly dosing of trastuzumab emtansine (T-DM1) in patients with advanced human epidermal growth factor 2-positive breast cancer
    Journal Article

    Beeram, M.; Krop, I. E.; Burris, H. A.; Girish, S. R.; Yu, W.; Lu, M. W.; Holden, S. N.; Modi, S.
    Cancer (2012)

    Fulltext@MSK | Save
  • A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity
    Journal Article

    Beasley, G. M.; Coleman, A. P.; Raymond, A.; Sanders, G.; Selim, M. A.; Peterson, B. L.; Brady, M. S.; Davies, M. A.; Augustine, C.; Tyler, D. S.
    Annals of Surgical Oncology (2012)

    Fulltext@MSK | Save
  • Insulin-like growth factor-I concentration and risk of prostate cancer: Results from the European prospective investigation into cancer and nutrition
    Journal Article

    Price, A. J.; Allen, N. E.; Appleby, P. N.; Crowe, F. L.; Travis, R. C.; Tipper, S. J.; Overvad, K.; Grønbæk, H.; Tjønneland, A.; Johnsen, N. F.; more...
    Cancer Epidemiology Biomarkers and Prevention (2012)

    Fulltext@MSK | Save
  • Factors associated with local-regional recurrence after a negative sentinel node dissection: Results of the ACOSOG Z0010 trial
    Journal Article

    Hunt, K. K.; Ballman, K. V.; McCall, L. M.; Boughey, J. C.; Mittendorf, E. A.; Cox, C. E.; Whitworth, P. W.; Beitsch, P. D.; Leitch, A. M.; Buchholz, T. A.; more...
    Annals of Surgery (2012)

    Fulltext@MSK | Save
  • Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401
    Journal Article

    Kelly, W. K.; Halabi, S.; Carducci, M.; George, D.; Mahoney, J. F.; Stadler, W. M.; Morris, M.; Kantoff, P.; Monk, J. P.; Kaplan, E.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Anthracycline-related cardiomyopathy after childhood cancer: Role of polymorphisms in carbonyl reductase genes - A report from the Children's Oncology Group
    Journal Article

    Blanco, J. G.; Sun, C. L.; Landier, W.; Chen, L.; Esparza-Duran, D.; Leisenring, W.; Mays, A.; Friedman, D. L.; Ginsberg, J. P.; Hudson, M. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • OCEANS: A randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
    Journal Article

    Aghajanian, C.; Blank, S. V.; Goff, B. A.; Judson, P. L.; Teneriello, M. G.; Husain, A.; Sovak, M. A.; Yi, J.; Nycum, L. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression
    Journal Article

    Mason, W. P.; Belanger, K.; Nicholas, G.; Vallieres, I.; Mathieu, D.; Kavan, P.; Desjardins, A.; Omuro, A.; Reymond, D.
    Journal of Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer
    Journal Article

    Pietanza, M. C.; Gadgeel, S. M.; Dowlati, A.; Lynch, T. J.; Salgia, R.; Rowland, K. M. Jr; Wertheim, M. S.; Price, K. A.; Riely, G. J.; Azzoli, C. G.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Olsen, M. R.; Hudes, G. R.; Burke, J. M. ; Edenfield, W. J.; Wilding, G.; Agarwal, N.; Thompson, J. A.; Cella, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save